Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Interest Coverage Ratio (2020 - 2024)

Seres Therapeutics (MCRB) has disclosed Interest Coverage Ratio for 5 consecutive years, with 55.72 as the latest value for Q1 2024.

  • Quarterly Interest Coverage Ratio fell 53.83% to 55.72 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 196.3 through Dec 2024, down 881.94% year-over-year, with the annual reading at 79.05 for FY2023, 164.51% down from the prior year.
  • Interest Coverage Ratio hit 55.72 in Q1 2024 for Seres Therapeutics, down from 15.54 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 91.94 in Q3 2021 to a low of 66.98 in Q4 2021.
  • Historically, Interest Coverage Ratio has averaged 28.48 across 5 years, with a median of 36.23 in 2023.
  • Biggest YoY gain for Interest Coverage Ratio was 323.77% in 2021; the steepest drop was 184.05% in 2021.
  • Year by year, Interest Coverage Ratio stood at 23.58 in 2020, then crashed by 184.05% to 66.98 in 2021, then soared by 98.63% to 0.92 in 2022, then soared by 1787.7% to 15.54 in 2023, then tumbled by 458.6% to 55.72 in 2024.
  • Business Quant data shows Interest Coverage Ratio for MCRB at 55.72 in Q1 2024, 15.54 in Q2 2023, and 36.23 in Q1 2023.